WitrynaThe journal’s impact factor of 24.8 places it as one of the highest-ranking oncology journals. Evaluating and selecting the best manuscripts for publication in the journal … Witryna5 lip 2024 · Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: a review. ... JAMA Oncol. 2024;5(10):e191870. doi: ... Early impact of COVID-19 on the conduct of oncology clinical trials and long-term opportunities for transformation: findings from an American Society of Clinical Oncology Survey.
Journal Metrics Nature Reviews Clinical Oncology
Witryna2374-2437 (print) 2374-2445 (web) Links. Journal homepage. Online access. Online archive. JAMA Oncology is a monthly peer-reviewed medical journal published by the American Medical Association. It covers all aspects of medical oncology, radiation oncology, and surgical oncology, as well as subspecialties. The journal was … WitrynaMain Outcomes and Measures Overall survival time and all-cause mortality. Results Median (range) age of 3241 women included in this study was 54 (18-80) years, and … how to score vanderbilt teacher assessment
About The Lancet Oncology
Witryna1 lis 2024 · Effect of Metformin Plus Tyrosine Kinase Inhibitors Compared With Tyrosine Kinase Inhibitors Alone in Patients With Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: A Phase 2 Randomized Clinical Trial ... JAMA Oncol. 2024 Nov 1;5(11):e192553. doi: 10.1001/jamaoncol.2024.2553. Epub 2024 Nov 14. Witryna23 mar 2024 · JAMA Oncology—The Year in Review, 2024 Oncology JAMA Oncology JAMA Network This past year has been an exciting one for JAMA Oncology and its … WitrynaIt measures the number of times an average paper in a particular journal has been referred to elsewhere in scientific literature. The Impact Factor of journal J in the calendar year X is the number of citations received by J in X to any item published in J in (X-1) or (X-2), divided by the number of source items published in J in (X-1) or (X-2). north ottawa care center grand haven mi